Race Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.5%.

Top 25 shareholders own 34.46% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.1%	Daniel Tillett	17,267,615	€19.0m	0%	no data
4.21%	Phillip Perry	7,169,078	€7.9m	5%	no data
4.02%	John Cullity	6,855,700	€7.5m	-32.1%	no data
3.43%	Mark Juan	5,839,062	€6.4m	3.11%	no data
2.61%	Merchant Funds Management Pty Ltd	4,450,468	€4.9m	0%	38.25%
1.08%	Marinella Messina	1,845,245	€2.0m	5%	no data
0.95%	Sandor Helby	1,625,000	€1.8m	14.8%	no data
0.88%	Kudoss Investments Pty Ltd	1,500,000	€1.6m	20%	no data
0.8%	Anthony Robinson	1,370,262	€1.5m	-6.29%	no data
0.64%	Alan Sauran	1,094,368	€1.2m	6.12%	no data
0.56%	Brian Walker	955,000	€1.0m	16.5%	no data
0.56%	Pierpont Investments Pty Ltd	950,000	€1.0m	0%	no data
0.55%	Surpion Pty Ltd	935,000	€1.0m	20.7%	no data
0.49%	Tetyana Perry	834,750	€916.4k	5%	no data
0.49%	Quy Do Van	829,409	€910.5k	0.44%	no data
0.46%	Jennifer Gartrell	787,500	€864.5k	5%	no data
0.46%	Kimberley Gartrell	787,500	€864.5k	5%	no data
0.43%	Adra Future Co Ltd	730,001	€801.4k	0%	no data
0.4%	Kasajumi Holdings Pty Ltd	680,817	€747.4k	0%	no data
0.32%	Catherine Ridley	540,000	€592.8k	0%	no data
0.32%	Kenneth Ridley	540,000	€592.8k	0%	no data
0.26%	Phillip Lynch	450,606	€494.7k	0%	no data
0.2%	Graeme Pocknall	337,256	€370.2k	0%	no data
0.2%	Vivienne Pocknall	337,255	€370.2k	0%	no data
0.014%	Mary Harney	24,570	€27.0k	0%	no data